T-win platform | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

364,977 results for “T-win platform”

IO Biotech Explores Strategic Alternatives as Cancer Vaccine Developer Faces Financial Pressures

IO Biotech Unveils Promising Preclinical Data for Next-Generation Cancer Vaccines Targeting Tumor Microenvironment

IO Biotech's Cancer Vaccine Shows 25.5-Month Median Progression-Free Survival in Five-Year Melanoma Study

IO Biotech's Cylembio Plus Pembrolizumab Demonstrates Clinical Improvement in Advanced Melanoma Phase 3 Trial

IO Biotech's Novel Immune-Modulatory Cancer Vaccine Shows Promise in Phase 3 Trials

IO Biotech's Cylembio Cancer Vaccine Misses Primary Endpoint in Phase 3 Melanoma Trial

Cabaletta Bio Receives FDA Clearance for Automated CAR-T Manufacturing Platform

CAR-E Platform Shows Promise in Preventing CAR-T Cell Therapy Relapse

Breakthrough Epigenetic Editing Platform Enables Safe Multi-Gene Modification in CAR-T Cells

Elicera Therapeutics Faces U.S. Patent Setback for iTANK CAR-T Enhancement Platform

Page 1 of 2606